Several States Have Tightened Telehealth Prescribing Rules for GLP-1 Drugs
In response to concerns about inadequate clinical evaluation, some states have updated telemedicine rules affecting how GLP-1 drugs can be prescribed remotely.
By the GLP Semaglutide editorial team · Last updated September 20, 2025
State medical boards set telemedicine practice standards, and several states have updated requirements around synchronous evaluation, informed consent, or documentation specifically in response to concerns about high-volume, low-scrutiny GLP-1 telehealth prescribing.
What tends to change
Common updates include requiring a live video or phone evaluation rather than a questionnaire alone, clearer disclosure of compounded versus FDA-approved products, and documentation requirements tying a prescription to an actual clinical assessment.
Rules are state-specific
Telemedicine practice rules are set at the state level and differ meaningfully — a platform's compliance in one state doesn't guarantee compliance in another. State medical board websites are the authoritative source for current requirements.
Primary sources